Skip to content
Search

Latest Stories

Global Covid-19 cases surge amid emergence of JN.1 variant

The latest spike has prompted health authorities in multiple countries

JN.1 Variant Drives Global Spike in Covid-19 Cases

India has also recorded a slight uptick in Covid-19 cases

iStock

Covid-19 cases are rising once again across several parts of the world, driven by the spread of the JN.1 variant – a new sub-lineage of Omicron known for its high transmissibility. While symptoms remain mostly mild, the latest spike has prompted health authorities in multiple countries to issue fresh public health advisories.

Cases are rising across Asia

Singapore has seen a sharp increase in cases, with 14,200 infections reported in the week ending 3 May, up from 11,100 the previous week. Hospital admissions also rose to an average of 133 per day, though the number of patients requiring intensive care fell slightly from three to two daily.


Hong Kong’s Centre for Health Protection described current virus activity as “quite high”, with the city recording its highest rate of respiratory samples testing positive in over a year. Authorities are monitoring the situation closely.

In Thailand, the latest surge is mostly affecting people aged 30 to 39, with health experts warning of more cases in the coming weeks. China, too, is experiencing a resurgence, although official figures remain limited.

India reports a modest increase

India has also recorded a slight uptick in Covid-19 cases. As of 19 May, the country had 257 active infections, with Kerala reporting the highest number (69), followed by Maharashtra (44) and Tamil Nadu (34). According to experts, most cases remain mild and do not require hospitalisation.

Health officials say the rise is partly due to the spread of the JN.1 variant, a drop in population-level immunity, and seasonal factors affecting people’s health. The increase in international travel is also believed to be contributing to the current wave.

What is the JN.1 variant?

The JN.1 variant has been labelled a “variant of interest” by global health bodies because of how quickly it spreads. Its symptoms include fever, sore throat, fatigue and mild respiratory issues. However, the severity of illness appears to remain low, particularly among those who have been vaccinated.

The variant has not been linked to increased hospital admissions or deaths, but public health authorities continue to urge caution.

Global health response

Authorities in affected countries are encouraging people to wear masks in crowded spaces, practise good hand hygiene, and stay home if they experience symptoms. While lockdowns and strict restrictions are not currently being considered, local measures could be introduced if hospital pressures increase.

In response to the broader pandemic preparedness challenge, the World Health Organisation recently adopted a historic Pandemic Agreement. The new framework aims to improve global cooperation and ensure a more equitable response to future pandemics, particularly in low- and middle-income countries.

As the world continues to navigate waves of Covid-19, experts are reminding the public not to become complacent. With new variants likely to emerge, maintaining basic precautions remains crucial in preventing further spread.

More For You

West Nile virus detected in UK mosquitoes

The virus is transmitted via the bird-biting mosquitoes from Britain

gettyimages

West Nile virus detected in UK mosquitoes, health officials confirm

The presence of West Nile virus has been detected in mosquitoes in the UK, health officials said. The UK Health Security Agency (UKHSA) has stated that the general public faces a “very low” risk from the virus, although it can cause serious illness in rare cases.

Authorities said there is currently no evidence of further spread of the virus among mosquito populations.

Keep ReadingShow less
England Pioneers Global Gonorrhoea Vaccine Rollout

The vaccine will be offered through local authority-commissioned sexual health services

Getty

England to roll out world-first gonorrhoea vaccine

England is set to become the first country in the world to introduce a national gonorrhoea vaccination programme, in a move hailed by health officials as a “landmark moment for sexual health”. The rollout will begin on 1 August 2025 and will use an existing meningitis B vaccine, known as 4CMenB, to help combat soaring cases of gonorrhoea and growing concerns over antibiotic resistance.

The sexually transmitted infection (STI) reached record levels in England in 2023, with more than 85,000 cases reported — the highest number since records began in 1918. Health experts have warned that strains of the bacteria responsible for gonorrhoea, neisseria gonorrhoeae, are becoming increasingly resistant to current treatments.

Keep ReadingShow less
Malayali nurse invited to Buckingham Palace

Her journey reflects the challenges many international healthcare workers face

Indian Express

Malayali nurse invited to Buckingham Palace for supporting international NHS staff

A nurse from Kerala who has worked to support fellow Malayali professionals in the UK has been invited to attend King Charles III’s garden party at Buckingham Palace in recognition of her contributions to the NHS and international nursing community.

Prabin Baby, 45, who currently works as a patient experience nurse in Hertfordshire, received the invitation in acknowledgement of her efforts to help internationally trained nurses, particularly from Kerala, integrate into the British healthcare system.

Keep ReadingShow less
The Sattva Collective launches to support South Asian women

The initiative will empower more women to speak openly about their health

iStock

The Sattva Collective launches to support South Asian women through midlife and menopause

A new community-led initiative has been launched in the UK to provide culturally sensitive support for South Asian women navigating midlife and menopause.

The Sattva Collective, founded by certified Midlife and Menopause Coach Kiran Singh, officially launched on 14 May 2025 as a registered Community Interest Company (CIC). It is the first initiative in the UK focused specifically on the experiences of South Asian women during what Singh describes as a “deeply personal and often stigmatised” phase of life.

Keep ReadingShow less
Zepbound Surpasses Wegovy in Groundbreaking Weight Loss Study

This may influence future decisions on treatment options for obesity patients

iStock

Eli Lilly's Zepbound outshines Wegovy in weight loss trial results

Eli Lilly announced on Sunday that its weight-loss drug, Zepbound, outperformed Novo Nordisk's Wegovy in a head-to-head trial, showing superior results across five weight-loss targets, including waist circumference reduction.

This trial, the first of its kind comparing the two widely used obesity medications, offers Eli Lilly a competitive advantage as it aims to secure broader insurance coverage in the rapidly growing obesity drug market, which is projected to exceed $150 billion annually by the next decade.

Keep ReadingShow less